EMA push towards transparency
Added: Thursday 7 February 2013
The executive director of the European Medicines Agency has confirmed that the Agency is committed to greater transparency about data. The Agency is now working towards proactive publication of clinical trial data. It is currently consulting on policy, with advisory groups working on five key areas.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: